➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
AstraZeneca
Johnson and Johnson
Dow
Boehringer Ingelheim

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Litigation Details for PLUMBERS & PIPEFITTERS LOCAL 178 HEALTH & WELFARE TRUST FUND v. TEVA PHARMACEUTICALS USA, INC. (E.D. Pa. 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

PLUMBERS & PIPEFITTERS LOCAL 178 HEALTH & WELFARE TRUST FUND v. TEVA PHARMACEUTICALS USA, INC. (E.D. Pa. 2013)

Docket   Start Trial Date Filed 2013-11-18
Court District Court, E.D. Pennsylvania Date Terminated 2014-04-09
Cause 15:1 Antitrust Litigation Assigned To Mitchell S. Goldberg
Jury Demand Plaintiff Referred To
Parties BARR LABORATORIES INC.; BARR PHARMACEUTICALS INC.; BOEHRINGER INGELHEIM INTERNATIONAL GMBH; BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG.; BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.; DURAMED PHARMACEUTICAL SALES CORP.; DURAMED PHARMACEUTICALS INC.; PLUMBERS & PIPEFITTERS LOCAL 178 HEALTH & WELFARE TRUST FUND; TEVA PHARMACEUTICAL INDUSTRIES LIMITED; TEVA PHARMACEUTICALS USA, INC.
Patents 6,015,577
Attorneys BARR LABORATORIES INC.; BARR PHARMACEUTICALS INC.; DURAMED PHARMACEUTICAL SALES CORP.; DURAMED PHARMACEUTICALS INC.; EDWARD D. ROGERS; JEANNINE M. KENNEY; LEE ALBERT; PAUL J. KOOB; TEVA PHARMACEUTICALS USA, INC.
Firms Ballard Spahr LLP; Ballard, Spahr, Andrews and Ingersoll; Glancy Prongay & Murray LLP; Hausfeld LLP
Link to Docket External link to docket
Small Molecule Drugs cited in PLUMBERS & PIPEFITTERS LOCAL 178 HEALTH & WELFARE TRUST FUND v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for PLUMBERS & PIPEFITTERS LOCAL 178 HEALTH & WELFARE TRUST FUND v. TEVA PHARMACEUTICALS USA, INC. (E.D. Pa. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-11-18 1 submitted Patent No. 6,015,577 (the ‘577 Patent) to the FDA for listing in the Orange Book. This patent was …that the new patents claim either the approved drug (for compound patents) of that the patents claim the… ‘577 Patent, asserting that its generic would not infringe the patents and/or that the patents were …the case of method-of-use patents, the FDA lists in the Orange Book any patents that (according to the …13 Page 12 of 48 the patent(s) at issue. If the NDA-holder initiates a patent infringement action against External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Mallinckrodt
Harvard Business School
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.